Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable RNA binding activity. Acts upstream of or within cellular response to leukemia inhibitory factor. Is active in synapse. Is expressed in several structures, including early embryo; gut; nervous system; ovary; and sensory organ. Orthologous to human ELAVL2 (ELAV like RNA binding protein 2).